PRNewsWire
18 Sept 2025, 14:00 UTC · 52w ago
Verdict
Headline takes no side. We score INSP −1.00 across four claims — strongly bearish.
−1.00strongly bearish
More negative than 96% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
Inspire Medical Systems significantly reduced its 2025 diluted net income per share guidance from $2.20-$2.30 down to $0.40-$0.50.
So whatA drastic reduction in earnings guidance typically triggers a severe valuation correction and signal fundamental business deterioration.
More negative than 98% of claims this week
Inspire lowered its full-year revenue outlook to $900 million - $910 million from previous guidance of $940 million - $955 million.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Search tags
More negative than 86% of claims this week
The guidance reductions were attributed to slower-than-expected commercial progress of the next generation Inspire V neurostimulation system.
More negative than 81% of claims this week
Pomerantz LLP is investigating claims of securities fraud and unlawful business practices against Inspire and its officers.
More negative than 73% of claims this week
Which stocks this story touches
More negative than 96% of ticker scores this week
The company is facing a securities fraud investigation, reduced financial guidance, and a significant stock price drop.
More negative than 88% of ticker scores this week
The company is being investigated by a law firm for claims on behalf of investors.
More negative than 88% of ticker scores this week
The company is being investigated by a law firm for claims on behalf of investors.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
−8.1%
Price agrees with the score
$73.56 vs $80.00 close before publication (Sep 17) · not market-adjusted
INSP chart →
